SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001722024-19-000015
Filing Date
2019-06-27
Accepted
2019-06-27 18:42:17
Documents
1
Period of Report
2019-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_156167532300076.html 3  
1 FORM 3 wf-form3_156167532300076.xml 3 3225
  Complete submission text file 0001722024-19-000015.txt   4786
Mailing Address 385 EAST COLORADO BOULEVARD SUITE 299 PASADENA CA 91101
Business Address 385 EAST COLORADO BOULEVARD SUITE 299 PASADENA CA 91101 626-578-0777
Alexandria Venture Investments, LLC (Reporting) CIK: 0001722024 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38958 | Film No.: 19926805

Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Issuer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902
SIC: 2834 Pharmaceutical Preparations